Home Fecal Immunochemical Test Detects 79% of Colorectal CancersGastroenterology and Endoscopy
Annals of Internal Medicine examined the accuracy of fecal immunochemical tests, an at-home stool test, as colon cancer screening tool, according to a Medscape report.
The researchers found that the test is able to accurately detect 79 percent of colorectal cancers. In comparison fecal occult blood tests, the other at-home colorectal cancer test, detect 13 to 50 percent of colorectal cancers.
The researchers did not compare FIT with colonoscopy, so the question of whether or not FIT followed by colonoscopy should become the new standard screening method remains unanswered.
More Articles on Gastroenterology:
8 Statistics on Irritable Bowel Disease
2014 CPT Code Update: GI/Endoscopy
6 Updates on Medicare & GI Reimbursement for Gastroenterologists to Know
© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
New from Becker's ASC Review
Colonoscopy surveillance lessens risk of CRC in IBDRead Now
- Qui tam suits on the rise emphasizes need for ASC compliance plans
- To prevent patient leakage, turn to technology
- Real estate considerations for ASCs
- The Amazon.com for ASCs: Using collaborative consumption to improve the bottom line
- Lolo Jones shares lessons for overcoming failure at Becker's ASC Annual Meeting